Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 24 | 2025 | 2065 | 3.440 |
Why?
|
| Glioma | 4 | 2022 | 99 | 2.110 |
Why?
|
| Meningomyelocele | 8 | 2010 | 11 | 1.770 |
Why?
|
| Brain Neoplasms | 6 | 2024 | 303 | 1.610 |
Why?
|
| Brain Mapping | 8 | 2024 | 228 | 1.550 |
Why?
|
| Neuroimaging | 6 | 2024 | 145 | 1.170 |
Why?
|
| Language Disorders | 5 | 2009 | 24 | 1.140 |
Why?
|
| Hydrocephalus | 6 | 2005 | 43 | 1.030 |
Why?
|
| Nerve Net | 3 | 2020 | 93 | 0.990 |
Why?
|
| Virus Diseases | 2 | 2016 | 114 | 0.910 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2016 | 1541 | 0.910 |
Why?
|
| Back Pain | 1 | 2023 | 49 | 0.830 |
Why?
|
| Diagnostic Imaging | 3 | 2016 | 246 | 0.820 |
Why?
|
| Sensorimotor Cortex | 1 | 2022 | 4 | 0.800 |
Why?
|
| Cerebellum | 1 | 2022 | 91 | 0.760 |
Why?
|
| Cerebral Cortex | 1 | 2022 | 250 | 0.700 |
Why?
|
| Brain Diseases | 3 | 2021 | 71 | 0.690 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 131 | 0.680 |
Why?
|
| Prefrontal Cortex | 1 | 2019 | 111 | 0.580 |
Why?
|
| Brain | 10 | 2025 | 1495 | 0.580 |
Why?
|
| Humans | 44 | 2025 | 59744 | 0.550 |
Why?
|
| Social Environment | 2 | 2009 | 91 | 0.540 |
Why?
|
| Parasitic Diseases | 1 | 2016 | 6 | 0.530 |
Why?
|
| Laryngoplasty | 1 | 2016 | 1 | 0.520 |
Why?
|
| Vocal Cord Paralysis | 1 | 2016 | 10 | 0.520 |
Why?
|
| Neoplasms | 2 | 2023 | 1238 | 0.510 |
Why?
|
| Mycoses | 1 | 2016 | 46 | 0.510 |
Why?
|
| Language | 4 | 2024 | 133 | 0.500 |
Why?
|
| Algorithms | 3 | 2017 | 981 | 0.500 |
Why?
|
| Orbit | 1 | 2015 | 15 | 0.490 |
Why?
|
| Family | 2 | 2009 | 229 | 0.490 |
Why?
|
| Bone Diseases | 1 | 2015 | 21 | 0.480 |
Why?
|
| Eye Diseases | 1 | 2015 | 35 | 0.480 |
Why?
|
| Spinal Dysraphism | 3 | 2005 | 16 | 0.480 |
Why?
|
| Bacterial Infections | 1 | 2016 | 140 | 0.470 |
Why?
|
| Prion Diseases | 1 | 2014 | 10 | 0.460 |
Why?
|
| Central Nervous System Infections | 1 | 2014 | 7 | 0.460 |
Why?
|
| Male | 30 | 2025 | 27952 | 0.460 |
Why?
|
| Female | 29 | 2025 | 30926 | 0.450 |
Why?
|
| Temperament | 2 | 2004 | 20 | 0.450 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2014 | 170 | 0.440 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2015 | 179 | 0.440 |
Why?
|
| Radiation Protection | 1 | 2013 | 25 | 0.420 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2013 | 31 | 0.420 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2013 | 69 | 0.410 |
Why?
|
| Radiation Dosage | 1 | 2013 | 128 | 0.400 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 191 | 0.400 |
Why?
|
| Child | 16 | 2025 | 4215 | 0.390 |
Why?
|
| Head and Neck Neoplasms | 1 | 2013 | 148 | 0.380 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2024 | 38 | 0.370 |
Why?
|
| Emergency Medical Services | 1 | 2015 | 260 | 0.370 |
Why?
|
| Critical Care | 1 | 2015 | 402 | 0.360 |
Why?
|
| Cysts | 1 | 2011 | 40 | 0.360 |
Why?
|
| Frontal Lobe | 2 | 2021 | 64 | 0.330 |
Why?
|
| Liver Diseases | 1 | 2011 | 138 | 0.330 |
Why?
|
| Adult | 14 | 2025 | 15771 | 0.330 |
Why?
|
| Ventriculoperitoneal Shunt | 3 | 2003 | 30 | 0.320 |
Why?
|
| Language Tests | 3 | 2005 | 39 | 0.310 |
Why?
|
| Stroke | 2 | 2015 | 1134 | 0.310 |
Why?
|
| Radiosurgery | 2 | 2020 | 61 | 0.310 |
Why?
|
| Cerebrospinal Fluid Shunts | 3 | 2005 | 10 | 0.280 |
Why?
|
| Middle Aged | 12 | 2024 | 16452 | 0.280 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2020 | 145 | 0.270 |
Why?
|
| Child, Preschool | 8 | 2025 | 1802 | 0.270 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2006 | 5 | 0.260 |
Why?
|
| Limbic System | 1 | 2006 | 27 | 0.260 |
Why?
|
| Abnormalities, Multiple | 1 | 2006 | 52 | 0.250 |
Why?
|
| Retrospective Studies | 8 | 2024 | 6156 | 0.250 |
Why?
|
| Rest | 3 | 2020 | 44 | 0.250 |
Why?
|
| Child Language | 1 | 2005 | 9 | 0.250 |
Why?
|
| Memory | 1 | 2006 | 111 | 0.240 |
Why?
|
| Gangliosidosis, GM1 | 1 | 2025 | 19 | 0.230 |
Why?
|
| Learning | 1 | 2006 | 172 | 0.230 |
Why?
|
| Tumor Burden | 2 | 2022 | 61 | 0.230 |
Why?
|
| Case-Control Studies | 5 | 2025 | 1061 | 0.210 |
Why?
|
| Parents | 2 | 2004 | 369 | 0.210 |
Why?
|
| Epilepsy | 1 | 2024 | 105 | 0.200 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 305 | 0.200 |
Why?
|
| Hand | 2 | 2020 | 69 | 0.200 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2022 | 21 | 0.190 |
Why?
|
| Adolescent | 7 | 2025 | 5866 | 0.190 |
Why?
|
| Neck | 2 | 2018 | 46 | 0.180 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 943 | 0.170 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 171 | 0.160 |
Why?
|
| Contrast Media | 2 | 2020 | 408 | 0.160 |
Why?
|
| Motor Cortex | 1 | 2020 | 72 | 0.160 |
Why?
|
| Young Adult | 5 | 2025 | 4290 | 0.150 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 6 | 0.150 |
Why?
|
| Thumb | 1 | 2018 | 27 | 0.150 |
Why?
|
| Antigens, CD19 | 1 | 2018 | 19 | 0.150 |
Why?
|
| Functional Laterality | 1 | 2019 | 134 | 0.150 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2018 | 20 | 0.150 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2018 | 69 | 0.150 |
Why?
|
| Neural Pathways | 1 | 2018 | 96 | 0.150 |
Why?
|
| Adoptive Transfer | 1 | 2018 | 148 | 0.140 |
Why?
|
| Cytokines | 2 | 2021 | 913 | 0.140 |
Why?
|
| Genetic Therapy | 1 | 2024 | 735 | 0.140 |
Why?
|
| Aged | 9 | 2024 | 13513 | 0.140 |
Why?
|
| Lymphoma | 1 | 2018 | 99 | 0.140 |
Why?
|
| Prognosis | 4 | 2024 | 1613 | 0.140 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2016 | 2 | 0.130 |
Why?
|
| Orbital Diseases | 1 | 2016 | 9 | 0.130 |
Why?
|
| Nose Diseases | 1 | 2016 | 9 | 0.130 |
Why?
|
| Pharyngeal Diseases | 1 | 2016 | 10 | 0.130 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 2390 | 0.130 |
Why?
|
| Meninges | 1 | 2016 | 10 | 0.130 |
Why?
|
| Mouth Diseases | 1 | 2016 | 13 | 0.130 |
Why?
|
| Biomarkers | 1 | 2022 | 1315 | 0.130 |
Why?
|
| Cerebral Angiography | 2 | 2015 | 282 | 0.130 |
Why?
|
| Preoperative Care | 1 | 2017 | 182 | 0.130 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 150 | 0.130 |
Why?
|
| Prostheses and Implants | 1 | 2016 | 67 | 0.130 |
Why?
|
| Infant | 4 | 2025 | 1496 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2018 | 286 | 0.120 |
Why?
|
| Critical Pathways | 1 | 2015 | 32 | 0.120 |
Why?
|
| Petrous Bone | 1 | 2014 | 3 | 0.110 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2014 | 7 | 0.110 |
Why?
|
| Intelligence | 2 | 2005 | 55 | 0.110 |
Why?
|
| Cochlear Nerve | 1 | 2014 | 8 | 0.110 |
Why?
|
| Mastoid | 1 | 2014 | 9 | 0.110 |
Why?
|
| Ear, Inner | 1 | 2014 | 16 | 0.110 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2014 | 48 | 0.110 |
Why?
|
| Follow-Up Studies | 3 | 2024 | 2354 | 0.110 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 988 | 0.110 |
Why?
|
| Oxygen | 2 | 2018 | 315 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 1570 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2024 | 5150 | 0.100 |
Why?
|
| Prospective Studies | 4 | 2020 | 3090 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 605 | 0.100 |
Why?
|
| Disease Progression | 3 | 2025 | 1127 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2018 | 653 | 0.090 |
Why?
|
| Caroli Disease | 1 | 2011 | 1 | 0.090 |
Why?
|
| Hamartoma | 1 | 2011 | 7 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2010 | 2387 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 1104 | 0.090 |
Why?
|
| Ileum | 1 | 2010 | 22 | 0.080 |
Why?
|
| Cell Transplantation | 1 | 2009 | 39 | 0.080 |
Why?
|
| Acidosis | 1 | 2010 | 26 | 0.080 |
Why?
|
| Urologic Surgical Procedures | 1 | 2010 | 35 | 0.080 |
Why?
|
| Survival Rate | 2 | 2024 | 804 | 0.080 |
Why?
|
| Dyslexia | 1 | 2009 | 8 | 0.080 |
Why?
|
| Intelligence Tests | 1 | 2009 | 25 | 0.080 |
Why?
|
| Language Development | 1 | 2009 | 10 | 0.080 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2009 | 30 | 0.080 |
Why?
|
| Colon | 1 | 2010 | 136 | 0.080 |
Why?
|
| Optic Chiasm | 1 | 2008 | 6 | 0.070 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 2008 | 4 | 0.070 |
Why?
|
| Aging | 1 | 2014 | 712 | 0.070 |
Why?
|
| Optic Nerve | 1 | 2008 | 25 | 0.070 |
Why?
|
| Optic Nerve Diseases | 1 | 2008 | 18 | 0.070 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2009 | 174 | 0.070 |
Why?
|
| Nanostructures | 1 | 2009 | 173 | 0.070 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2006 | 6 | 0.070 |
Why?
|
| Fornix, Brain | 1 | 2006 | 10 | 0.070 |
Why?
|
| Orientation | 1 | 2005 | 27 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2016 | 5334 | 0.060 |
Why?
|
| Self-Assessment | 1 | 2005 | 60 | 0.060 |
Why?
|
| Culture | 1 | 2005 | 73 | 0.060 |
Why?
|
| Personality Assessment | 1 | 2004 | 28 | 0.060 |
Why?
|
| Atrophy | 1 | 2025 | 76 | 0.060 |
Why?
|
| Central Nervous System Diseases | 1 | 2024 | 56 | 0.060 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 65 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2009 | 606 | 0.050 |
Why?
|
| Perception | 1 | 2004 | 168 | 0.050 |
Why?
|
| Attention | 1 | 2005 | 146 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2005 | 742 | 0.050 |
Why?
|
| Achievement | 1 | 2002 | 27 | 0.050 |
Why?
|
| Faculty | 1 | 2002 | 51 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2024 | 305 | 0.050 |
Why?
|
| Cognition | 1 | 2005 | 457 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 404 | 0.050 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 2021 | 3 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1192 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 1038 | 0.040 |
Why?
|
| Age Factors | 1 | 2003 | 1511 | 0.040 |
Why?
|
| Time Factors | 2 | 2018 | 3629 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2024 | 809 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 1489 | 0.040 |
Why?
|
| Carcinoma, Large Cell | 1 | 2018 | 5 | 0.040 |
Why?
|
| Dependovirus | 1 | 2024 | 653 | 0.040 |
Why?
|
| Body Water | 1 | 2018 | 16 | 0.040 |
Why?
|
| Probability | 1 | 2018 | 170 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2018 | 75 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2018 | 51 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 922 | 0.030 |
Why?
|
| Comorbidity | 1 | 2021 | 1083 | 0.030 |
Why?
|
| United States | 2 | 2017 | 7448 | 0.030 |
Why?
|
| Artifacts | 1 | 2018 | 127 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2004 | 2520 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 168 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2018 | 281 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 218 | 0.030 |
Why?
|
| Head | 1 | 2016 | 53 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 239 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 327 | 0.030 |
Why?
|
| Collateral Circulation | 1 | 2014 | 22 | 0.030 |
Why?
|
| Animals | 3 | 2024 | 19705 | 0.030 |
Why?
|
| Observer Variation | 1 | 2014 | 206 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2014 | 175 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2014 | 402 | 0.020 |
Why?
|
| Porosity | 1 | 2009 | 38 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2014 | 1289 | 0.020 |
Why?
|
| Anisotropy | 1 | 2009 | 58 | 0.020 |
Why?
|
| Membranes, Artificial | 1 | 2009 | 45 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 225 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2008 | 29 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 592 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2009 | 461 | 0.020 |
Why?
|
| Radiography | 1 | 2008 | 519 | 0.020 |
Why?
|
| Incidence | 1 | 2010 | 1245 | 0.020 |
Why?
|
| Rats | 1 | 2009 | 1911 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2009 | 2095 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2005 | 216 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2005 | 377 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 3240 | 0.010 |
Why?
|
| Mice | 1 | 2009 | 10317 | 0.010 |
Why?
|